North America Cancer Tissue Diagnostics Market Size, Trends, Competitors Strategy, Regional Analysis and Growth by Forecast to 2027

The North America cancer tissue diagnostics market is expected to reach US$ 1,587.38 Mn in 2027 from US$ 923.79 Mn in 2018. The market is estimated to grow with a CAGR of 6.5% from 2019-2027.


The growth of the market is driven by the factors such as, growing cancer prevalence in North American region and new product launches & FDA approvals. However, the market is likely to slower down its growth due to the lack of reimbursement policies for cancer diagnosis in the region.

📚 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐂𝐨𝐩𝐲@ https://www.businessmarketinsights.com/sample/TIPRE00006459

Frequent FDA approvals and product launches fuel the growth of the market for cancer tissue diagnostics. Most of the major market players are involved in the manufacturing wide range of cancer diagnostics products that offer maximum advantages and early diagnosis. For instance, in June 2019, Agilent Technologies Inc. received the U.S. Food and Drug Administration (FDA) approval for its PD-L1 IHC 22C3 pharmDx assay. The assay is approved to aim in identifying patients with head and neck squamous cell carcinoma (HNSCC) for treatment with KEYTRUDA (pembrolizumab), anti-PD-1 therapy manufactured by Merck. Furthermore, In March 2018, Agilent Technologies Inc. launched a new color for immunohistochemistry: HRP Magenta for Dako Omnis. The latest staining characteristics of the chromogen will help it for the assessment of skin and lung tissue. Thus, the constant developments in technology in diagnostics along with, FDA approvals accelerate the market growth during the forecast period.

US is expected to lead the market in the North America region owing to increasing prevalence of cancer, improved diagnosis and treatment of the condition along with the advancements made by market players. Moreover, the country has several hospitals, super specialty hospitals which offers diagnostic and treatment services for the cardiovascular diseases. Therefore, considering the above mentioned factors the growth of the market in the country is likely to contribute largest share in the North America region during the forecast period.

📚𝐅𝐮𝐥𝐥 𝐑𝐞𝐩𝐨𝐫𝐭 𝐋𝐢𝐧𝐤 @ https://www.businessmarketinsights.com/reports/north-america-cancer-tissue-diagnostics-market

𝐓𝐡𝐞 𝐋𝐢𝐬𝐭 𝐨𝐟 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬

F. Hoffmann-La Roche Ltd

Thermo Fisher Scientific Inc.

Bio Rad Laboratories Inc.

Abbott

Enzo Life Sciences, Inc.

Agilent Technologies, Inc.

Cancer Genetics Inc.

Merck KGaA (Sigma-Aldrich Co. LLC)

Danaher Corporation

Abcam plc

North America Cancer Tissue Diagnostics Market

The North America Cancer Tissue Diagnostics market is a rapidly evolving sector within the global healthcare industry. This market primarily involves the use of advanced diagnostic tools and techniques to detect and diagnose various forms of cancer in tissue samples. The rise in the prevalence of cancer, along with advancements in technology, is driving significant growth in the cancer tissue diagnostics market. In North America, particularly in the United States and Canada, there is a strong focus on improving diagnostic accuracy, expanding access to testing, and enhancing treatment outcomes for patients.

Market Overview

Cancer is one of the leading causes of death in North America. According to the American Cancer Society, an estimated 1.9 million new cancer cases are expected to be diagnosed in the United States in 2025, with nearly 600,000 deaths from the disease. This highlights the urgent need for effective and timely diagnostic tools that can accurately detect cancer at various stages of progression. Tissue diagnostics, including techniques like immunohistochemistry (IHC), in situ hybridization (ISH), and molecular diagnostics, play a pivotal role in identifying the presence of cancer and providing information that can guide treatment decisions.

The North American Cancer Tissue Diagnostics market includes technologies and services that enable the diagnosis of cancer at the tissue level. This includes a wide range of diagnostic methods that involve tissue samples, ranging from routine biopsy procedures to more advanced genetic and molecular analyses. In particular, the market has been shaped by the increasing adoption of personalized medicine, where cancer diagnosis is not just about identifying the presence of cancer but understanding its genetic and molecular profile to guide treatment.

Key Market Drivers

  1. Increasing Cancer Incidence: One of the primary drivers for the North America Cancer Tissue Diagnostics market is the rising incidence of cancer. As populations age, the incidence of cancer is expected to continue increasing. Factors such as lifestyle changes, genetic predisposition, environmental factors, and an aging population contribute to the growing number of cancer cases. This drives demand for diagnostic tools that can detect cancer at its earliest stages.
  2. Technological Advancements: The cancer tissue diagnostics market is witnessing a surge in the development of innovative diagnostic tools. Technologies such as next-generation sequencing (NGS), digital pathology, and liquid biopsy are revolutionizing how cancer is detected and diagnosed. These technologies enable the detection of molecular and genetic mutations that are critical for identifying specific types of cancer and guiding treatment decisions. For instance, NGS allows for the analysis of multiple genes and mutations in a single test, offering a more comprehensive understanding of the cancer’s genetic makeup.
  3. Growing Demand for Personalized Medicine: Personalized medicine has emerged as a significant trend in oncology, where treatments are tailored to individual patients based on their genetic and molecular profiles. Tissue diagnostics, particularly genetic and molecular profiling, play a critical role in identifying specific biomarkers that can guide the choice of treatment. This shift toward personalized medicine is driving the demand for sophisticated diagnostic tools and tests.
  4. Government Initiatives and Healthcare Funding: Governments in North America, especially in the U.S. and Canada, have been investing heavily in cancer research and healthcare infrastructure. Various government bodies and healthcare organizations are focusing on improving early cancer detection, funding cancer research, and increasing access to advanced diagnostic services. Programs such as the Cancer Moonshot Initiative in the U.S. and initiatives by the National Cancer Institute (NCI) are helping to accelerate the development and adoption of innovative diagnostic technologies.
  5. Increased Awareness and Early Detection Programs: Public awareness campaigns about the importance of early cancer detection have increased over the years. Screening programs for common cancers such as breast cancer, prostate cancer, and colorectal cancer have been promoted by healthcare organizations, which has led to an increase in biopsy procedures and tissue samples being collected for diagnostic testing.

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:

Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications

The list Of Companies-

3D and 4D Technology Market- https://www.openpr.com/news/3921417/3d-and-4d-technology-market-segments-opportunities-regional

Last Mile Delivery Market- https://www.openpr.com/news/3921138/last-mile-delivery-market-global-analysis-size-share

Europe Barbeque Grill Market- https://www.openpr.com/news/3921830/europe-barbeque-grill-market-segments-opportunities

 


Comments

Post a Comment

Popular posts from this blog

Europe Electric Ship Market Key Players, Growth, Trends, Share, Opportunities, Forecast 2028

Image
  The Europe electric ship market is expected to grow from US$ 1867.68 million in 2021 to US$ 3273.91 million by 2028; it is estimated to grow at a CAGR of 8.3% from 2021 to 2028. The Europe Electric Ship Market is experiencing significant growth due to increasing environmental awareness, advancements in maritime technologies, and the urgent need to reduce emissions from the shipping industry. This market is driven by the demand for eco-friendly solutions in the maritime sector, and electric ships offer a promising alternative to traditional fossil-fuel-powered vessels. With stricter environmental regulations being implemented across Europe, the Europe Electric Ship Market is expected to expand rapidly in the coming years. Electric ships are designed to operate on electric power, utilizing batteries or other renewable energy sources instead of conventional marine fuels like diesel or heavy fuel oil. These vessels are not only more environmentally friendly but also help reduce ope...
Read more

Europe Electric Ship Market Key Players, Growth, Trends, Share, Opportunities, Forecast 2028

Image
  The Europe electric ship market is expected to grow from US$ 1867.68 million in 2021 to US$ 3273.91 million by 2028; it is estimated to grow at a CAGR of 8.3% from 2021 to 2028. Several marine industry associations are focusing on reducing the gas emission from the shipping industry. For instance, according to a report published by the Norwegian Ministry of Climate and Environment, in April 2018, the International Maritime Organization (IMO) adopted a plan to reduce greenhouse gas emissions from international shipping by at least 50% by the end of 2050 compared with the level in 2008. Additionally, the IMO strategy includes ambitions to improve the energy efficiency of each ship and to reduce the carbon intensity of the whole marine industry by reducing emissions per unit of transport work done by at least 40% by 2030 and further towards 70% by 2050, according to report published by the Norwegian Ministry of Climate and Environment. Also, in January 2020, according to IMO 2020 ...
Read more

Europe Electric Ship Market Key Details and Outlook by Top Companies till 2028

Image
  The Europe electric ship market is expected to grow from US$ 1867.68 million in 2021 to US$ 3273.91 million by 2028; it is estimated to grow at a CAGR of 8.3% from 2021 to 2028. The Europe Electric Ship Market is experiencing robust growth due to the increasing focus on reducing carbon emissions in the maritime industry. The push towards sustainable transportation has significantly accelerated the adoption of electric propulsion technologies in ships across Europe. Governments and maritime authorities are implementing strict emission regulations, further propelling the demand for electric ships in the region. As a result, the Europe Electric Ship Market is emerging as a key component in achieving Europe’s green transportation objectives. The Europe Electric Ship Market is primarily driven by the rising need for cleaner and more efficient marine transport solutions. Traditional ships powered by fossil fuels contribute significantly to greenhouse gas emissions and marine pollut...
Read more